FALLS CHURCH, Va., Aug. 3, 2016 -- Northrop Grumman Corporation (NYSE:NOC) has received a U.S. Navy contract to begin production of a second Japanese E-2D Advanced Hawkeye airborne early warning (AEW) and surveillance aircraft.
|
|||||
The first Japanese E-2D is in production and will be delivered in 2018.
A photo accompanying this release is available at: http://media.globenewswire.com/noc/mediagallery.html?pkgid=40965
The aircraft will be produced at the company's Aircraft Integration Center of Excellence in St. Augustine, Florida. Northrop Grumman will manufacture the Japanese E-2D on the same multiyear production line used for U.S. aircraft, which allows for a more efficient and affordable delivery schedule. The E-2D is the world's only AEW aircraft in production.
"For more than 50 years, Northrop Grumman has partnered with Japan by providing a range of capabilities and technologies in defense, security and communications," said Jane Bishop, vice president, E-2D Advanced Hawkeye programs, Northrop Grumman. "We are honored to continue this strong partnership through the E-2D program, which brings Japan a powerful new tool that meets their immediate airborne surveillance needs and facilitates information sharing across many platforms, making it a force multiplier for the future as well."
In 2014, the Japanese Ministry of Defense competitively selected the E-2D to fulfill the nation's AEW requirements. The Japan Air Self-Defense Force has operated the E-2C Hawkeye since the 1983. The E-2C is also currently used by Taiwan, France and Egypt.
Northrop Grumman is a leading global security company providing innovative systems, products and solutions in autonomous systems, cyber, C4ISR, strike, and logistics and modernization to customers worldwide. Please visit www.northropgrumman.com for more information.
CONTACT: Lindsay McLaurin
703-280-4705 (office)
804-239-3851 (mobile)
[email protected]


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



